Conditions + Treatments

Kidney Transplantation Research

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Contact the Kidney Transplant Program

Boston Children's Hospital is home to the world’s largest research program at a pediatric institution, and we’re known for pioneering new treatments. We also have a great number of partnerships with top research, biotech and health care organizations. Several years ago, Children’s Hospital Boston partnered with the Brigham and Woman’s Hospital to form the Transplantation Research Center (TRC).This merging of resources:

  • provides a rich environment for collaboration of scientists and physicians
  • ensures that your child has access to the most up-to-date treatments and strategies available

Scientists in our Kidney Transplant Program are leaders in pediatric kidney transplant research, and their goal is to bring their innovations to your child’s bedside as quickly as possible.

Since 1994, we have participated in every NIH-sponsored pediatric kidney transplant research study – more than any other program in the nation. The results of these studies have led to significant improvements to your child’s post-transplant treatment options, including the development of steroid-free protocols that may allow her to avoid such undesirable side effects as obesity, diabetes and heart and liver disease.

One of our current goals is to make your child’s post-transplant life easier by reducing the number of immunosuppressive medications she must take to just one. This will not only further minimize any side effects she might experience, but it also makes the regimen easier to follow.

Current and upcoming studies at Boston Children’s include:

  • a trial that requires children to take only one chronic immunosuppressive medication after their kidney transplant
  • a study designed to learn why some children, particularly adolescents, may not take their medications as prescribed, and what we can do to help them
  • a study that determines whether:
  • children develop antibodies after transplantation
  • those antibodies cause long-term damage to the kidneys
  • a new medication may stop the production of those antibodies

Elliott's Journey

Elliott Cleckler was born with long-gap esophageal atresia – a serious condition that is notoriously difficult to treat. In this short video series, his parents, Jay and Heather, share their story.

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944